Dinactin: A New Antitumor Antibiotic with Cell Cycle Progression and Cancer Stemness Inhibiting Activities in Lung Cancer

• Main Authors: Anchalee Rawangkan (Author), Pattama Wongsirisin (Author), Grissana Pook-In (Author), Achiraya Siriphap (Author), Atchariya Yosboonruang (Author), Anong Kiddee (Author), Jureeporn Chuerduangphui (Author), Nanthawan Reukngam (Author), Acharaporn Duangjai (Author), Surasak Saokaew (Author), Ratsada Praphasawat (Author)
• Format: Book
• Published: MDPI AG, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Lung cancer, especially non-small cell lung cancer (NSCLC), is one of the most complex diseases, despite the existence of effective treatments such as chemotherapy and immunotherapy. Since cancer stem cells (CSCs) are responsible for chemo- and radio-resistance, metastasis, and cancer recurrence, fi...